ANI Pharmaceuticals, Inc. revenue for the last year amounted to 614.38 M USD, the most of which — 320.03 M USD — came from its highest performing source at the moment, Generics and Other. The greatest contribution to the revenue figure was made by United States — last year it brought ANI Pharmaceuticals, Inc. 604.99 M USD, and the year before that — 486.25 M USD.